14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PMCB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Pharmacyt Biotch
(Updated on May 03, 2024)

Hold candidate since May 02, 2024 Loss -2.31% PDF

The Pharmacyt Biotch stock price fell by -2.31% on the last day (Friday, 3rd May 2024) from $2.16 to $2.11. During the last trading day the stock fluctuated 4.29% from a day low at $2.10 to a day high of $2.19. The price has risen in 5 of the last 10 days but is still down by -0.47% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -8 thousand shares and in total, 3 thousand shares were bought and sold for approximately $7.27 thousand.

The stock has broken the wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $2.14. A reaction back to this level may hold a second chance to get out before further falls.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PMCB Signals & Forecast

There are mixed signals in the stock today. The Pharmacyt Biotch stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.12 and $2.26. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Pharmacyt Biotch stock

Pharmacyt Biotch finds support from accumulated volume at $2.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0900 between high and low, or 4.29%. For the last week the stock has had daily average volatility of 3.97%.

Our recommended stop-loss: $1.98 (-6.00%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (PMCB) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Pharmacyt Biotch to open at $2.13, and during the day (based on 14 day Average True Range), to move between $2.00 and $2.22, which gives a possible trading interval of +/-$0.110 (+/-5.21%) up or down from last closing price. If Pharmacyt Biotch takes out the full calculated possible swing range there will be an estimated 10.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.14 (1.42%) than the support at $2.06 (2.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pharmacyt Biotch stock A Buy?

Pharmacyt Biotch holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.062 Hold/Accumulate Unchanged

Predicted Opening Price for Pharmacyt Biotch of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$2.13 ( 1.11%) $2.11

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PMCB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.22 5.37 %
R2 2.19 3.74 %
R1 2.17 2.74 %
Current price: 2.11
Support S1 2.10 -0.524 %
S2 2.08 -1.53 %
S3 2.04 -3.16 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.44 15.64 %
R2 2.38 12.80 %
R1 2.14 1.42 %
Current price 2.11
Support S1 2.06 -2.37%
S2 2.05 -2.84%
S3 2.01 -4.74%

FAQ

What is the symbol for Pharmacyt Biotch Stock and on which exchange is it traded?
The symbol for Pharmacyt Biotch is PMCB and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Pharmacyt Biotch Stock?
Pharmacyt Biotch holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Pharmacyt Biotch Stock?
Pharmacyt Biotch Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pharmacyt Biotch Stock.

What's the current price of Pharmacyt Biotch Stock?
As of the end of day on the May 03, 2024, the price of an Pharmacyt Biotch (PMCB) share was $2.11.

What is the 52-week high and low for Pharmacyt Biotch Stock?
The 52-week high for Pharmacyt Biotch Stock is $3.23 and the 52-week low is $1.92.

What is the market capitalization of Pharmacyt Biotch Stock?
As of the May 03, 2024, the market capitalization of Pharmacyt Biotch is 17.861M.

When is the next earnings date for Pharmacyt Biotch?
The upcoming earnings date for Pharmacyt Biotch is Jul 29, 2024.
Click to get the best stock tips daily for free!

About Pharmacyt Biotch

Pharmacyt Biotch PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developin... PMCB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT